Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas
about
An interstitial network of podoplanin-expressing cells in the human endolymphatic ductThe potential role of podoplanin in tumour invasionPodoplanin - a small glycoprotein with many facesModel membranes to shed light on the biochemical and physical properties of ezrin/radixin/moesinPodoplanin mediates ECM degradation by squamous carcinoma cells through control of invadopodia stabilityThe platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasisConcordant podoplanin expression in cancer-associated fibroblasts and tumor cells is an adverse prognostic factor in esophageal squamous cell carcinomaPodoplanin: emerging functions in development, the immune system, and cancerLow podoplanin expression in pretreatment biopsy material predicts poor prognosis in advanced-stage squamous cell carcinoma of the uterine cervix treated by primary radiationTargeting a novel domain in podoplanin for inhibiting platelet-mediated tumor metastasisEpithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma: Characterization in a 3D-cell culture modelGalectin-8 interacts with podoplanin and modulates lymphatic endothelial cell functions.Podoplanin associates with CD44 to promote directional cell migrationSyk and Src family kinases regulate C-type lectin receptor 2 (CLEC-2)-mediated clustering of podoplanin and platelet adhesion to lymphatic endothelial cells.Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cellsThe role of podoplanin in the biology of differentiated thyroid cancers.A cancer-specific monoclonal antibody recognizes the aberrantly glycosylated podoplanin.Tumor lymphangiogenesis and metastasis to lymph nodes induced by cancer cell expression of podoplanin.Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomasExtracellular matrix mineralization promotes E11/gp38 glycoprotein expression and drives osteocytic differentiationThe tumour-associated glycoprotein podoplanin is expressed in fibroblast-like synoviocytes of the hyperplastic synovial lining layer in rheumatoid arthritisRelationship between LYVE-1, VEGFR-3 and CD44 gene expressions and lymphatic metastasis in gastric cancer.Are podoplanin and ezrin involved in the invasion process of the ameloblastomas?Podoplanin promotes the invasion of oral squamous cell carcinoma in coordination with MT1-MMP and Rho GTPases.EphrinA1-EphA2 signal induces compaction and polarization of Madin-Darby canine kidney cells by inactivating Ezrin through negative regulation of RhoAExpression of Podoplanin in Different Grades of Oral Squamous Cell CarcinomaLpMab-12 Established by CasMab Technology Specifically Detects Sialylated O-Glycan on Thr52 of Platelet Aggregation-Stimulating Domain of Human Podoplanin.PKA and CDK5 can phosphorylate specific serines on the intracellular domain of podoplanin (PDPN) to inhibit cell motilityPlant lectin can target receptors containing sialic acid, exemplified by podoplanin, to inhibit transformed cell growth and migration.Phosphorylated mTOR expression correlates with podoplanin expression and high tumor grade in esophageal squamous cell carcinoma.Podoplanin in the development and progression of oral cavity cancer: a preliminary study.The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity.Genome-wide two-locus epistasis scans in prostate cancer using two European populationsSerines in the intracellular tail of podoplanin (PDPN) regulate cell motility.High expression of podoplanin in squamous cell carcinoma of the tongue occurs predominantly in patients ≤40 years but does not correlate with tumour spread.Podoplanin-mediated TGF-β-induced epithelial-mesenchymal transition and its correlation with bHLH transcription factor DEC in TE-11 cells.Podoplanin is a component of extracellular vesicles that reprograms cell-derived exosomal proteins and modulates lymphatic vessel formationRole of podoplanin expression in deciding the invasive potential of ameloblastoma - A retrospective IHC study.HuR and podoplanin expression is associated with a high risk of malignant transformation in patients with oral preneoplastic lesions.The Hepatic Lymphatic Vascular System: Structure, Function, Markers, and Lymphangiogenesis.
P2860
Q24646973-680AF732-1163-4439-A61E-998157958714Q24653540-A6BF7857-1E7A-445E-9B21-D82D3C6D12D0Q26749146-C2D4D54A-860B-4B85-A829-8EE3B9D47AA7Q27004665-78B90422-94AD-4491-9D25-4EAD7836ACDAQ27310083-93A2668F-D308-4889-9FD1-F97EABF1A4D1Q28221740-79BE67A4-4A28-4B8E-8ACC-AED97AFE8906Q28247458-852B4684-637E-4CAF-B914-79FB7E7FD013Q28275310-118789FD-574B-4383-BB26-377A38348044Q28301253-DB852FC6-7441-432F-B36F-67695BE65BA2Q28600973-6CCB48A3-6F0D-48ED-9DBD-18353970C01DQ28603184-5683F437-0FC0-4F24-B71C-95C8C2AA8AFFQ30032684-C2A29800-1394-4078-9335-1026468BE74BQ30090217-63312A5B-0F19-4742-A5D8-605C524FD994Q30611441-C72BE4AE-C9EA-4C43-A7DC-4C4ACD550628Q33277291-74B39034-47BE-4B71-BE41-9D065A84C4CBQ33568168-4633A3A8-A861-43B2-A103-EEA24887E7F7Q33985502-E27D091F-B3EF-4619-A9B2-4539B3500169Q34033409-20DD8399-DBF0-453A-853E-55DB702F14A4Q34160649-BBD8510E-37A7-4A90-B5C2-597019B0BD20Q34269222-941FDCE6-D79F-4833-801B-C5A4A0D53ED4Q35092895-847743F1-B144-4037-8B6F-897A4F4768FBQ35171541-1C9FD14A-4A6C-4799-A024-E60D803B82AFQ35228782-270B6672-454E-4A56-A6BE-B4222DFC0B95Q35402652-06DD2793-357C-4732-8139-5CBD7237FFD7Q35626109-1B7A41AA-6CEB-409B-A3E8-63FB90583E02Q35729186-F6E566F1-6ECD-43F8-AAB9-9D1818AD7D66Q35975006-9085A7DF-2B67-468F-8FF3-ABEC804D92AFQ36015517-FAC651E5-B72C-4896-8FA2-862D570158CAQ36109632-848E3E63-C19B-4F2B-A81E-B350308084EBQ36375220-600A5EF0-CE6B-4A8C-B632-53B1C42928B8Q36419637-8F5E531D-45BB-4BD6-A23F-514CF693B17EQ36546538-9087BB9D-0F5E-40FD-9C05-F222B7706D85Q36790692-7EC856BE-0B6D-4BD0-8766-75DF5E42FD8FQ36796918-138DEA3D-BC74-441F-B56D-C74175038A1AQ36873805-AF41F0A4-296D-4E43-B2EC-B6A3CAF499FFQ36891662-53C923FD-3EA8-4A34-AD2C-1A3755F96CECQ37085956-59272BC5-E5E2-4EA3-9DC8-5BCBD563FB71Q37340960-5FD6E8F2-AF47-4C3F-885C-886251354711Q37406862-957911EB-7961-4584-93C1-46A3953B6EF3Q37588806-2D94DA4B-5FC3-4457-8FFD-D115EC22B582
P2860
Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Characterization of human PA2. ...... oral squamous cell carcinomas
@ast
Characterization of human PA2. ...... oral squamous cell carcinomas
@en
Characterization of human PA2. ...... oral squamous cell carcinomas
@nl
type
label
Characterization of human PA2. ...... oral squamous cell carcinomas
@ast
Characterization of human PA2. ...... oral squamous cell carcinomas
@en
Characterization of human PA2. ...... oral squamous cell carcinomas
@nl
prefLabel
Characterization of human PA2. ...... oral squamous cell carcinomas
@ast
Characterization of human PA2. ...... oral squamous cell carcinomas
@en
Characterization of human PA2. ...... oral squamous cell carcinomas
@nl
P2093
P2860
P3181
P356
P1476
Characterization of human PA2. ...... oral squamous cell carcinomas
@en
P2093
Carlos Gamallo
Ester Martín-Villar
Francisco G Scholl
Jesús Cruces
Maria M Yurrita
Mario Muñoz-Guerra
Miguel Quintanilla
P2860
P304
P3181
P356
10.1002/IJC.20656
P407
P577
2005-03-01T00:00:00Z